Mon, January 7, 2019
Fri, January 4, 2019
Thu, January 3, 2019
Wed, January 2, 2019
Mon, December 31, 2018
Fri, December 28, 2018
Thu, December 27, 2018
Wed, December 26, 2018
Fri, December 21, 2018
Thu, December 20, 2018
Wed, December 19, 2018
Tue, December 18, 2018
Mon, December 17, 2018
Fri, December 14, 2018
Thu, December 13, 2018
Wed, December 12, 2018
Tue, December 11, 2018
Mon, December 10, 2018
Fri, December 7, 2018
Thu, December 6, 2018
Wed, December 5, 2018
Tue, December 4, 2018
Mon, December 3, 2018

Elemer Piros Maintained (ARWR) at Buy with Increased Target to $165 on, Dec 17th, 2018


  Copy link into your clipboard //stocks-investing.news-articles.net/content/201 .. th-increased-target-to-165-on-dec-17th-2018.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI


Elemer Piros of Cantor Fitzgerald, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Buy with Increased Target from $145 to $165 on, Dec 17th, 2018.

Elemer has made no other calls on ARWR in the last 4 months.



There are 2 other peers that have a rating on ARWR. Out of the 2 peers that are also analyzing ARWR, 0 agree with Elemer's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Elemer


  • Keay Nakae of "Chardan Capital" Maintained at Strong Buy with Increased Target to $25 on, Thursday, September 6th, 2018
  • Madhu Kumar of "B. Riley Securities" Upgraded from Hold to Strong Buy on, Thursday, September 6th, 2018

Publication Contributing Sources